Orofacial Manifestations Associated with Muscular Dystrophies: A Review

Orofacial Manifestations Associated with Muscular Dystrophies: A Review

The aim of this review is to evaluate the developmental, functional, and morphological aspects of the craniofacial complex in patients with myotonic dystrophy type 1 (DM1), Facioscapulohumeral muscular dystrophy (FSHD), and Duchenne muscular dystrophy (DMD). The degree of disease onset and severity...

Full description

Bibliographic Details
Main Authors:	Petros Papaefthymiou, Kyriaki Kekou, Fulya Özdemir
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2022-03-01
Series:	Turkish Journal of Orthodontics
Subjects:	genetic myopathies myotonic dystrophy type 1 facioscapulohumeral muscular dystrophy duchenne muscular dystrophy dentofacial morphology
Online Access:	http://www.turkjorthod.org/archives/archive-detail/article-preview/orofacial-manifestations-associated-with-muscular-/53299

Similar Items

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
by: José Luis García-Giménez, et al.
Published: (2022-12-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Meeting report: the 2020 FSHD International Research Congress
by: Michael Kyba, et al.
Published: (2020-12-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Molecular targets to treat muscular dystrophies
by: Jochen Kinter, et al.
Published: (2014-02-01)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
by: Darko Bosnakovski, et al.
Published: (2017-10-01)

A team approach in the diagnosis and management of facioscapulohumeral muscular dystrophy: a case report
by: Robert L. Parisien, MD, et al.
Published: (2020-09-01)

The development of myasthenia gravis in a patient with facioscapulohumeral muscular dystrophy: case report and literature review
by: Feryal Nauman, et al.
Published: (2019-06-01)

Duchenne muscular dystrophy: Genetic and clinical profile in the population of Rajasthan, India
by: Manisha Goyal, et al.
Published: (2021-01-01)

Muscular dystrophies: key elements for everyday diagnosis and management
by: Alberto Palladino, et al.
Published: (2013-12-01)

Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study
by: Edyta Blaszczyk, et al.
Published: (2021-11-01)

On the Role of Delays to Diagnosis of Facioscapulohumeral Muscular Dystrophy
by: Elan Schonfeld, et al.
Published: (2022-09-01)

Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01)

Progress in research on molecular mechanism of facioscapulohumeral muscular dystrophy
by: Xiao-dan LIN, et al.
Published: (2017-08-01)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
by: Martina Sandonà, et al.
Published: (2023-02-01)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

Research advance and application prospect of therapeutic strategies for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Review the history of Duchenne muscular dystrophy and seize the cutting-edge research
by: Cheng ZHANG
Published: (2015-05-01)

A comprehensive database of Duchenne and Becker muscular dystrophy patients in Children's Hospital of Fudan University
by: Xi-hua LI, et al.
Published: (2015-05-01)

Duchenne and Becker muscular dystrophy in adolescents: current perspectives
by: Andrews JG, et al.
Published: (2018-03-01)

Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
by: Ilaria Andreana, et al.
Published: (2021-02-01)

Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy
by: Xu X, et al.
Published: (2021-04-01)

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01)

Nutritional Status of Patients with Facioscapulohumeral Muscular Dystrophy
by: Sedda Amzali, et al.
Published: (2023-03-01)

Advance and cogitation of gene therapy for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2019-05-01)

Prepare for the era of gene therapy for Duchenne muscular dystrophy
by: Cheng ZHANG
Published: (2019-05-01)

Combined Lumbar-Sacral Plexus Block in Facioscapulohumeral Muscular Dystrophy for Hip Fracture Surgery: A Case Report
by: Mete Manici, et al.
Published: (2024-02-01)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
by: Finsterer J, et al.
Published: (2016-03-01)

The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies
by: Woo Hyun Yoo, et al.
Published: (2017-06-01)

The research status and problems of Duchenne muscular dystrophy in China
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States
by: Erika J. Mejia, et al.
Published: (2022-04-01)

Motor clinical progression in a series of pediatric Duchenne and Becker muscular dystrophy cases
by: Zakiah Nur Istianah, et al.
Published: (2019-03-01)

Muscular Dystrophy /
by: Naff, Clay Farris, editor 192865, et al.
Published: (2012)

Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study
by: Liang Wang, et al.
Published: (2017-05-01)

The ratios of estradiol and progesterone to testosterone influence the severity of facioscapulohumeral muscular dystrophy
by: Ceren Hangul, et al.
Published: (2020-01-01)

Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
by: Ana Valéria de Araujo Leitão, et al.